Karuna Therapeutics Investor Relations Material
Latest events
Q3 2023
Karuna Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Karuna Therapeutics Inc
Access all reports
Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurological and psychiatric disorders. The company's research focuses on discovering and utilizing novel pathways for medications that aim to significantly improve the lives of those affected by conditions such as schizophrenia and dementia-related psychosis. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
KRTX
Country
🇺🇸 United States